Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies
Phase of Trial: Phase I
Latest Information Update: 18 Feb 2019
At a glance
- Drugs Trichostatin A (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions
- Sponsors Vanda Pharmaceuticals
- 07 Nov 2018 According to a Vanda Pharmaceuticals media release, first patient was randomised in this trial in October 2018.
- 07 Nov 2018 Status changed from planning to recruiting, as reported in the Vanda Pharmaceuticals media release.
- 14 Feb 2018 According to a Vanda Pharmaceuticals media release, trial is expected to start in the second half of 2018.